Login to Your Account



Cytori Shares Spike on Potential $531M Cell Therapy Deal

By Marie Powers
Staff Writer

Tuesday, November 5, 2013

Cytori Therapeutics Inc. shares (NASDAQ:CYTX) headed skyward Tuesday morning after the company disclosed a deal with Chinese firm Lorem Vascular to commercialize Cytori cell therapy in the cardiovascular, renal and diabetes markets in China, Hong Kong, Malaysia, Singapore and Australia.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription